Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02137902 · ClinicalTrials.gov registry record · NA
Healing and Empowering Alaskan Lives Towards Healthy-Hearts Study
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 299
- Enrollment target
NCT02137902: Completed NA study, sponsored by Stanford University.
NCT02137902 is a NA study that has completed, run by Stanford University. The registered enrollment target is 299 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02137902, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 299 participants
- Enrollment target
Study Summary
This study aims to identify effective and cost-effective interventions for tobacco use and other risk behaviors for cardiovascular disease among Alaska Native people in rural villages. In a randomized controlled trial, the study will compare interventions using telemedicine to promote the American Heart Association's identified ideal health behaviors (nonsmoking and physical activity) relative to ideal health factors (managing cholesterol and blood pressure).
Primary Outcome
Change from baseline as no tobacco use, including a puff, in the past 7 days
Interventions
- BEHAVIORAL Tobacco/Physical Activity Intervention
- BEHAVIORAL Diet plus BP/CHOL Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 299 participants |
| Start Date | 2015-06-01 |
| Est. Completion | 2020-03 |
| Phase | NA |
What the finished NCT02137902 record still lists
NCT02137902 is an interventional study that assigns participants to a tested intervention. The registered 299 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower).
The record links to 0 conditions, and to 2 interventions - of which Tobacco/Physical Activity Intervention is the first listed.
NCT02137902 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02137902 about?
NCT02137902 is a clinical study titled "Healing and Empowering Alaskan Lives Towards Healthy-Hearts Study". This study aims to identify effective and cost-effective interventions for tobacco use and other risk behaviors for cardiovascular disease among Alaska Native people in rural villages. In a randomized controlled trial, the study will compare interventions using telemedicine to promote the American H...
What is the current status of trial NCT02137902?
This trial is currently completed. It is a NA study. The enrollment target is 299 participants. The study started on 2015-06-01. Estimated completion is 2020-03.
What interventions are being tested in trial NCT02137902?
The interventions under investigation include: Tobacco/Physical Activity Intervention (BEHAVIORAL), Diet plus BP/CHOL Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT02137902?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02137902's enrollment target sits among peer trials
299 371st of 2000 higher than 1,630 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI